Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)
Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)’s Financial Overview
Portola Pharmaceuticals, Inc. (NASDAQ) surged 1.28% yesterday to close its trading session at $29.37. The company has 1 year Price Target of $36.17. Portola Pharmaceuticals, Inc. has 52-Week high of $50.2 and 52-Week Low of $14.81. The stock touched its 52-Week High on 50.20 and 52-Week Low on 14.81. The stock traded with the volume of 1.12 Million shares yesterday. The firm shows the market capitalization of $1.94 Billion.
Portola Pharmaceuticals, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-1.08/share against the analyst consensus estimate of $-1.62/share. The difference between the actual and expected EPS is $0.54 a share with a surprise factor of 33.3%.
The firm is trading with SMA20 of 10.39 Percent, SMA50 of 31.12 Percent and SMA200 of -0.68 percent. Portola Pharmaceuticals, Inc. has P/S value of 56.16 while its P/B value stands at 11.8. Similarly, the company has Return on Assets of -69.7 percent, Return on Equity of -136.3 percent and Return on Investment of -60.4 Percent. The company shows Gross Margin and Operating Margin of 82.8 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 6 analysts offering 12-month price forecasts for Portola Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 49.00 and a low estimate of 27.00. The median estimate represents a +12.36% increase from the last price of 29.37.
Portola Pharmaceuticals, Inc. is expected* to report earnings on 03/01/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-1.09. The reported EPS for the same quarter last year was $-1.41.
SunTrust Banks, Inc. (NYSE:STI)
SunTrust Banks, Inc. is a purpose-driven company dedicated to Lighting the Way to Financial Well-Being for the people, businesses, and communities it serves. It operates through three segments: Consumer Banking and Private Wealth Management, Wholesale Banking, and Mortgage Banking. Its flagship subsidiary, SunTrust Bank, operates an extensive branch and ATM network throughout the high-growth Southeast and Mid-Atlantic states, along with 24-hour digital access. Certain business lines serve consumer, commercial, corporate, and institutional clients nationally. SunTrust had total assets of $208 billion and total deposits of $163 billion. The Company provides deposit, credit, trust, investment, mortgage, asset management, securities brokerage, and capital market services. SunTrust leads onUp, a national movement inspiring Americans to build financial confidence.
SunTrust Banks, Inc. (NYSE:STI)’s Financial Outlook
The 24 analysts offering 12-month price forecasts for SunTrust Banks Inc have a median target of 68.00, with a high estimate of 88.00 and a low estimate of 60.00. The median estimate represents a +3.72% increase from the last price of 65.56.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
According to Zacks Investment Research, SunTrust Banks, Inc. has a Consensus Recommendation of 2.26. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 1.22% and closed its last trading session at $65.56. The company has the market capitalization of $29.62 Billion. The stock has 52-week high of $75.08 and 52-Week low of $46.05. The firm touched its 52-Week high on 75.08 and 52-Week low on 46.05. The company has volume of 5.42 Million shares. The company has a total of 451.73 Million shares outstanding.
SunTrust Banks, Inc. (NYSE) in the last quarter reported its actual EPS of $1.5/share where the analyst estimated EPS was $1.38/share. The difference between the actual and Estimated EPS is $0.12. This shows a surprise factor of 8.7 percent.
The company has YTD performance of 29.98 percent. Beta for SunTrust Banks, Inc. stands at 1.52 while its ATR (average true range) is 1.57. The company has Weekly Volatility of 2.39%% and Monthly Volatility of 2.16%%.
SunTrust Banks, Inc. has distance from 20-day Simple Moving Average (SMA20) of 8.71%, Distance from 50-Day Simple Moving Average of 15.85 percent and Distance from 200-Day Simple Moving Average of 0.51%.
The Company currently has ROA (Return on Assets) of 1.2 percent, Return on Equity (ROE) of 11.3 Percent and Return on Investment (ROI) of 13.5% with Gross margin of 0 percent and Operating & Profit margin of 76.8% and 35.1% respectively.